bioAffinity Technologies (BIAF) Operating Income (2021 - 2026)
bioAffinity Technologies (BIAF) reported Operating Income of -$3.6 million for Q1 2026, down 37.68% year-over-year from -$5.8 million in Q1 2025, and down 15.3% quarter-over-quarter from -$3.1 million in Q4 2025.
bioAffinity Technologies (BIAF) Operating Income (2021 - 2026) Analysis & Trends
bioAffinity Technologies (BIAF) has 6 years of Operating Income data on file, last reported at -$3.6 million in Q1 2026.
- Operating Income for Q1 2026 came in at -$3.6 million, down 37.68% year-over-year; the trailing twelve-month figure through Mar 2026 was -$11.6 million (down 20.0% YoY), and the FY2025 annual result was -$10.6 million, down 18.08% from the prior year.
- Operating Income fell to -$3.6 million in Q1 2026 per BIAF's latest filing, from -$3.1 million in the prior quarter.
- Over five years, Operating Income peaked at -$684119.0 in Q2 2022 and troughed at -$3.6 million in Q1 2026.
- A 5-year average of -$2.1 million and a median of -$2.1 million in 2024 frame the typical range for Operating Income.
- The sharpest annual moves came in 2023 and 2024: Operating Income slumped 159.95% in 2023, then gained 13.97% in 2024.
- A 5-year view of Operating Income shows it stood at -$1.6 million in 2022, then slumped by 44.26% to -$2.3 million in 2023, then retreated by 25.79% to -$2.9 million in 2024, then decreased by 6.46% to -$3.1 million in 2025, then declined by 15.3% to -$3.6 million in 2026.
- Business Quant data shows BIAF's Operating Income at -$3.6 million in Q1 2026, -$3.1 million in Q4 2025, and -$2.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 30,529.42 Bn | 30,528.96 Bn | 1.11 Bn | -47.00 Mn |
| 2 | Thermo Fisher Scientific | 183.75 Bn | 180.50 Bn | 7.74 Bn | 1.86 Bn |
| 3 | Danaher | 133.13 Bn | 127.43 Bn | 3.59 Bn | 1.34 Bn |
| 4 | Idexx Laboratories | 46.14 Bn | 45.94 Bn | 722.74 Mn | 362.59 Mn |
| 5 | Agilent Technologies | 38.20 Bn | 36.39 Bn | 990.00 Mn | 399.00 Mn |
| 6 | Natera | 31.50 Bn | 30.40 Bn | 696.04 Mn | -93.52 Mn |
| 7 | Iqvia Holdings | 31.34 Bn | 29.36 Bn | 1.36 Bn | 514.00 Mn |
| 8 | Illumina | 24.51 Bn | 23.36 Bn | 721.00 Mn | 209.00 Mn |
| 9 | Mettler Toledo International | 23.53 Bn | 23.47 Bn | 555.82 Mn | 238.95 Mn |
| 10 | bioAffinity Technologies | 2.08 Mn | -1.02 Mn | - | -3.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.62 Mn |
| Dec 31, 2025 | -3.14 Mn |
| Sep 30, 2025 | -2.29 Mn |
| Jun 30, 2025 | -2.52 Mn |
| Mar 31, 2025 | -2.63 Mn |
| Dec 31, 2024 | -2.95 Mn |
| Sep 30, 2024 | -1.97 Mn |
| Jun 30, 2024 | -2.09 Mn |
| Mar 31, 2024 | -1.95 Mn |
| Dec 31, 2023 | -2.34 Mn |
| Sep 30, 2023 | -2.29 Mn |
| Jun 30, 2023 | -1.78 Mn |
| Mar 31, 2023 | -1.56 Mn |
| Dec 31, 2022 | -1.62 Mn |
| Sep 30, 2022 | -976,156.00 |
| Jun 30, 2022 | -684,119.00 |
| Mar 31, 2022 | -727,043.00 |
| Dec 31, 2021 | -659,752.00 |
| Sep 30, 2021 | -526,293.00 |